Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2016, Article ID 7097612, 8 pages
http://dx.doi.org/10.1155/2016/7097612
Research Article

Anesthetic Propofol-Induced Gene Expression Changes in Patients Undergoing Coronary Artery Bypass Graft Surgery Based on Dynamical Differential Coexpression Network Analysis

Department of Anesthesiology, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Ningbo, Zhejiang 315000, China

Received 8 April 2016; Revised 12 June 2016; Accepted 15 June 2016

Academic Editor: Emil Alexov

Copyright © 2016 Da Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Dickstein, A. Cohen-Solal, G. Filippatos et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008,” European Journal of Heart Failure, vol. 10, no. 10, pp. 933–989, 2008. View at Publisher · View at Google Scholar
  2. A. Rezaianzadeh, B. Maghsoudi, H. Tabatabaee et al., “Factors associated with extubation time in coronary artery bypass grafting patients,” Peer Journal, vol. 3, article e1414, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. L. Xie, Y. B. Pan, L. Q. Hu, and Y. N. Qian, “Propofol attenuates hydrogenperoxide-induced apoptosis in human umbilical vein endothelial cells via multiple signaling pathways,” Korean Journal of Anesthesiology, vol. 68, no. 5, pp. 488–495, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Chen, Y. Gu, Z. Shao, J. Luo, and Z. Tan, “Propofol protects against hydrogen peroxide-induced oxidative stress and cell dysfunction in human umbilical vein endothelial cells,” Molecular and Cellular Biochemistry, vol. 339, no. 1-2, pp. 43–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Ansley, J. Sun, W. A. Visser et al., “High dose propofol enhances red cell antioxidant capacity during CPB in humans,” Canadian Journal of Anaesthesia, vol. 46, no. 7, pp. 641–648, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Wang, J. Shravah, H. Luo, K. Raedschelders, D. D. Y. Chen, and D. M. Ansley, “Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation,” Biochemical and Biophysical Research Communications, vol. 389, no. 1, pp. 105–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. E. Cox, S. D. Reed, J. A. Govert et al., “An economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation,” Critical Care Medicine, vol. 36, no. 3, pp. 706–714, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. G. Klamt, L. V. Garcia, R. M. Stocche, and M. P. Dos Reis, “Continuous epidural anesthesia with 0.2% Ropivacaine associated to general anesthesia for upper abdominal surgery in children,” Revista Brasileira de Anestesiologia, vol. 53, no. 2, pp. 160–168, 2003. View at Google Scholar · View at Scopus
  9. M. M. Sayin, O. Özatamer, R. Taöz, K. Kilinç, and N. Ünal, “Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery,” British Journal of Anaesthesia, vol. 89, no. 2, pp. 242–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. D. He, Z.-P. Liu, M. Honda, S. Kaneko, and L. Chen, “Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma,” Journal of Molecular Cell Biology, vol. 4, no. 3, pp. 140–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Z.-P. Liu, Y. Wang, X.-S. Zhang, and L. Chen, “Network-based analysis of complex diseases,” IET Systems Biology, vol. 6, no. 1, pp. 22–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. K. Nibbe, S. A. Chowdhury, M. Koyutürk, R. Ewing, and M. R. Chance, “Protein-protein interaction networks and subnetworks in the biology of disease,” Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol. 3, no. 3, pp. 357–367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Wu, R. Jing, L. Jiang et al., “Combination use of protein-protein interaction network topological features improves the predictive scores of deleterious non-synonymous single-nucleotide polymorphisms,” Amino Acids, vol. 46, no. 8, pp. 2025–2035, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Emilsson, G. Thorleifsson, B. Zhang et al., “Genetics of gene expression and its effect on disease,” Nature, vol. 452, no. 7186, pp. 423–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Chen, R.-S. Wang, and X.-S. Zhang, “Transcription regulation: networks and models,” in Biomolecular Networks, pp. 23–45, John Wiley & Sons, New York, NY, USA, 2009. View at Google Scholar
  16. X. Ma, L. Gao, G. Karamanlidis et al., “Revealing pathway dynamics in heart diseases by analyzing multiple differential networks,” PLoS Computational Biology, vol. 11, no. 6, Article ID e1004332, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-Y. Sun, Z.-P. Liu, T. Zeng, Y. Wang, and L. Chen, “Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks,” Scientific Reports, vol. 3, article 2268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. R.-H. Li, A. Zhang, S. Li et al., “Multiple differential expression networks identify key genes in rectal cancer,” Cancer Biomarkers, vol. 16, no. 3, pp. 435–444, 2016. View at Publisher · View at Google Scholar
  19. D. K. Zhai, B. Liu, X. F. Bai, and J. A. Wen, “Identification of biomarkers and pathway-related modules involved in ovarian cancer based on topological centralities,” Journal of B.U.ON., vol. 21, no. 1, pp. 208–220, 2016. View at Google Scholar
  20. E. Segal, M. Shapira, A. Regev et al., “Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data,” Nature Genetics, vol. 34, no. 2, pp. 166–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Lucchinetti, C. Hofer, L. Bestmann et al., “Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics,” Anesthesiology, vol. 106, no. 3, pp. 444–457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Kolesnikov, E. Hastings, M. Keays et al., “ArrayExpress update—simplifying data submissions,” Nucleic Acids Research, vol. 43, no. 1, pp. D1113–D1116, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Von Mering, L. J. Jensen, B. Snel et al., “STRING: known and predicted protein-protein associations, integrated and transferred across organisms,” Nucleic Acids Research, vol. 33, supplement 1, pp. D433–D437, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Robinson, D. J. McCarthy, and G. K. Smyth, “edgeR: a bioconductor package for differential expression analysis of digital gene expression data,” Bioinformatics, vol. 26, no. 1, pp. 139–140, 2010. View at Google Scholar · View at Scopus
  25. X. Ma, L. Gao, and K. Tan, “Modeling disease progression using dynamics of pathway connectivity,” Bioinformatics, vol. 30, no. 16, pp. 2343–2350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Bouchard, A.-L. Jousselme, and P.-E. Doré, “A proof for the positive definiteness of the Jaccard index matrix,” International Journal of Approximate Reasoning, vol. 54, no. 5, pp. 615–626, 2013. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  27. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society, Series B: Methodological, vol. 57, no. 1, pp. 289–300, 1995. View at Google Scholar · View at MathSciNet
  28. J. C. Mar, N. A. Matigian, J. Quackenbush, and C. A. Wells, “Attract: a method for identifying core pathways that define cellular phenotypes,” PLoS ONE, vol. 6, no. 10, Article ID e25445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Kanehisa, M. Araki, S. Goto et al., “KEGG for linking genomes to life and the environment,” Nucleic Acids Research, vol. 36, no. 1, pp. D480–D484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Metaxas, H. L. Keyworth, J. H. Yoo, Y. Chen, I. Kitchen, and A. Bailey, “The stereotypy-inducing and OCD-like effects of chronic ‘binge’ cocaine are modulated by distinct subtypes of nicotinic acetylcholine receptors,” British Journal of Pharmacology, vol. 167, no. 2, pp. 450–464, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Ruggeri, G. Landoni, F. Guarracino, S. Scolletta, E. Bignami, and A. Zangrillo, “Remifentanil in critically ill cardiac patients,” Annals of Cardiac Anaesthesia, vol. 14, no. 1, pp. 6–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Samir, N. Gandreti, M. Madhere, A. Khan, M. Brown, and V. Loomba, “Anti-inflammatory effects of propofol during cardiopulmonary bypass: a pilot study,” Annals of Cardiac Anaesthesia, vol. 18, no. 4, pp. 495–501, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Aghdaii, M. Ziyaeifard, S. Z. Faritus, and R. Azarfarin, “Hemodynamic responses to two different anesthesia regimens in compromised left ventricular function patients undergoing coronary artery bypass graft surgery: etomidate-midazolam versus propofol-ketamine,” Anesthesiology and Pain Medicine, vol. 5, no. 3, Article ID e27966, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. E. Plummer, S. Baos, C. A. Rogers et al., “The effects of propofol cardioplegia on blood and myocardial biomarkers of stress and injury in patients with isolated coronary artery bypass grafting or aortic valve replacement using cardiopulmonary bypass: protocol for a single-center randomized controlled trial,” JMIR Research Protocols, vol. 3, no. 3, article e35, 2014. View at Publisher · View at Google Scholar
  35. F. K. Knop, T. Vilsbøll, S. Larsen et al., “Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution,” American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 1, pp. E324–E330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. P. B. Jeppesen, P. Lund, I. B. Gottschalck et al., “Short bowel patients treated for two years with glucagon-like peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function,” Gastroenterology Research and Practice, vol. 2009, Article ID 616054, 12 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. L. A. Nikolaidis, S. Mankad, G. G. Sokos et al., “Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion,” Circulation, vol. 109, no. 8, pp. 962–965, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Kitamura, M. Ogawa, G. Kawamura, K. Sato, and Y. Yamada, “The effects of sevoflurane and propofol on glucose metabolism under aerobic conditions in fed rats,” Anesthesia and Analgesia, vol. 109, no. 5, pp. 1479–1485, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. L. Primo-Parmo, R. C. Sorenson, J. Teiber, and B. N. La Du, “The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family,” Genomics, vol. 33, no. 3, pp. 498–507, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. G. S. Getz and C. A. Reardon, “Paraoxonase, a cardioprotective enzyme: continuing issues,” Current Opinion in Lipidology, vol. 15, no. 3, pp. 261–267, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Mackness and B. Mackness, “Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?” Free Radical Biology and Medicine, vol. 37, no. 9, pp. 1317–1323, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. W.-F. Li, C.-W. Sun, T.-J. Cheng, K.-H. Chang, C.-J. Chen, and S.-L. Wang, “Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan,” Toxicology and Applied Pharmacology, vol. 236, no. 2, pp. 246–253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. D. H. Mouhamed, A. Ezzaher, M. Araoud et al., “Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers,” Annales de Biologie Clinique, vol. 68, no. 2, pp. 143–147, 2009. View at Publisher · View at Google Scholar
  44. M. Wang, X. Lang, S. Cui et al., “Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk,” DNA and Cell Biology, vol. 31, no. 6, pp. 975–982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Zhao, Y. Ma, Y. Fang et al., “Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies,” Molecular Genetics and Metabolism, vol. 105, no. 1, pp. 141–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Wei, P. Ramanathan, I. C. Martin, C. Moran, R. M. Taylor, and P. Williamson, “Identification of gene sets and pathways associated with lactation performance in mice,” Physiological Genomics, vol. 45, no. 5, pp. 171–181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. J. P. Vázquez-Medina, I. Popovich, M. A. Thorwald et al., “Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 4, pp. H599–H607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Wang, X. Yu, F. Wang et al., “Yohimbine promotes cardiac NE release and prevents LPS-induced cardiac dysfunction via blockade of presynaptic α2A-adrenergic receptor,” PLoS ONE, vol. 8, no. 5, Article ID e63622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Zhou, H. J. Fontenot, S.-N. Wang, and R. H. Kennedy, “Propofol-induced alterations in myocardial β-adrenoceptor binding and responsiveness,” Anesthesia & Analgesia, vol. 89, no. 3, pp. 604–608, 1999. View at Publisher · View at Google Scholar · View at Scopus